Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark.
Acta Obstet Gynecol Scand. 2024 Jul;103(7):1408-1419. doi: 10.1111/aogs.14862. Epub 2024 May 22.
There is a paucity of objectively verified data on substance use among Danish pregnant women. We estimated the prevalence of substance use including alcohol and nicotine among the general population of Danish pregnant women.
In this anonymous, national, cross-sectional, descriptive study, pregnant women were invited when attending an ultrasound scan between November 2019 and December 2020 at nine Danish hospitals. Women submitted a urine sample and filled out a questionnaire. Urine samples were screened on-site with a qualitative urine dipstick for 15 substances including alcohol, nicotine, opioids, amphetamines, cannabis, and benzodiazepines. All screen-positive urine samples underwent secondary quantitative analyses with gold standard, liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Results were compared to questionnaire information to analyze the validity of self-reporting and to examine possible cross-reactions.
A total of 1903 of 2154 invited pregnant women participated (88.3%). The prevalence of dipstick-positive urine samples was 25.0%. 44.0% of these were confirmed positive, resulting in a total confirmed prevalence of 10.8%. The prevalence of nicotine use was 10.1%-and for all other substances, <0.5%. Nicotine use was more prevalent among younger pregnant women, while other substance use appeared evenly distributed over age groups. Self-reporting of use of nicotine products was high (71.1%), but low for cannabis and alcohol intake (0% and 33.3%, respectively). Prescription medication explained almost all cases of oxycodone, methylphenidate, and benzodiazepine use.
Substance use among pregnant women consisted mainly of nicotine. Dipstick screening involved risks of false negatives and false positives. Except for alcohol intake and cannabis use, dipstick analyses did not seem to provide further information than self-reporting. LC-MS/MS analyses remain gold standard, and future role of dipstick screenings should be discussed.
丹麦孕妇的物质使用情况缺乏客观验证的数据。我们估计了丹麦普通孕妇群体中包括酒精和尼古丁在内的物质使用的流行率。
在这项匿名、全国性、横断面、描述性研究中,我们邀请了 2019 年 11 月至 2020 年 12 月期间在丹麦 9 家医院接受超声扫描的孕妇参加。孕妇提交尿液样本并填写问卷。现场使用定性尿液试纸对尿液样本进行筛查,共筛查 15 种物质,包括酒精、尼古丁、阿片类、苯丙胺、大麻和苯二氮䓬。所有筛查阳性的尿液样本均采用液相色谱-串联质谱(LC-MS/MS)分析的金标准进行二次定量分析。将结果与问卷信息进行比较,以分析自我报告的有效性,并检查可能的交叉反应。
共有 2154 名受邀孕妇中的 1903 名(88.3%)参加了研究。尿液试纸阳性样本的流行率为 25.0%。其中 44.0%的样本经确认呈阳性,总确认流行率为 10.8%。尼古丁使用的流行率为 10.1%-所有其他物质的使用均<0.5%。尼古丁使用在年轻孕妇中更为普遍,而其他物质使用在年龄组中分布均匀。尼古丁制品使用的自我报告率较高(71.1%),但对大麻和酒精摄入的报告率较低(分别为 0%和 33.3%)。处方药物几乎可以解释所有羟考酮、哌甲酯和苯二氮䓬的使用情况。
孕妇的物质使用主要为尼古丁。试纸筛查存在假阴性和假阳性的风险。除酒精摄入和大麻使用外,试纸分析似乎并没有比自我报告提供更多的信息。LC-MS/MS 分析仍然是金标准,应进一步讨论试纸筛查的未来作用。